Imunon, Inc. (IMNN) Form S-1 — Oct 27, 2026
Imunon filed an S-1 for a best-efforts offering of up to 20,000,000 shares (or pre-funded warrants) at an assumed $1.25 per share, each sold with tranches of common warrants representing 350% aggregate warrant coverage over 70,000,000 shares. Maxim Group LLC is placement agent on a 7.0% cash fee plus 5.0% warrants, with no minimum offering amount required to close. The offering is enormous relative to the company's size: 20 million new shares against only 4,665,660 shares outstanding as of June 30, 2026, with warrant exercises potentially adding up to 70 million more shares. Estimated net proceeds are approximately $23 million at the maximum, versus just $6.9 million of cash on hand.
Key figures
- Total Assets
- 0
- Cash Position
- 6864378
- Gross Proceeds
- approximately $23 million net proceeds at maximum (estimated)
- Offering Price
- 1.25
- Shares Offered
- 20000000
- Shares Outstanding
- 4665660
- Warrant Shares
- 70000000
- Net Loss Q2 2026
- $2.8 million (Q2), $7.1 million (six months)
- Warrant Coverage
- 350%
- Dilution Per Share
- 0.22
- Placement Agent Fee
- 7.0% cash plus 5.0% warrants
- Cumulative Net Losses
- $428.4 million
- Tranche AExercise Price
- 1.25
- Tranche BExercise Price
- 1.38
- Tranche CExercise Price
- 1.56
- Tranche DExercise Price
- 2.5
- Placement Agent Warrants
- 1000000
- Pre Funded Warrant Exercise Price
- 0.0001
- Shares Outstanding Post Offering
- 24665600
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.